Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type
M Yamaguchi, R Suzuki… - Blood, The Journal of the …, 2018 - ashpublications.org
Extranodal natural killer/T-cell lymphoma, nasal type (ENKL) is a subtype of mature T-and
natural killer cell lymphomas characterized by its association with Epstein-Barr virus and …
natural killer cell lymphomas characterized by its association with Epstein-Barr virus and …
Extranodal NK/T cell lymphoma, nasal type (ENKTL-NT): an update on epidemiology, clinical presentation, and natural history in North American and European cases
BM Haverkos, Z Pan, AA Gru, AG Freud… - Current hematologic …, 2016 - Springer
Abstract Purpose of Review Extranodal NK/T cell lymphoma, nasal type (ENKTL-NT) is an
aggressive extranodal non-Hodgkin lymphoma most commonly occurring in East Asia and …
aggressive extranodal non-Hodgkin lymphoma most commonly occurring in East Asia and …
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a …
Extranodal NK/T-cell lymphoma, nasal type, is a rare and highly aggressive disease with a
grim prognosis. No therapeutic strategy is currently identified in relapsing patients. We report …
grim prognosis. No therapeutic strategy is currently identified in relapsing patients. We report …
Nutrition and carcinogenesis
AR Collins, LR Ferguson - Mutation Research/Fundamental and Molecular …, 2004 - Elsevier
Traditional views of nutritional carcinogenesis depend on the identification of exogenous
carcinogens as major risk factors. As our understanding evolves, it is clear that the pattern of …
carcinogens as major risk factors. As our understanding evolves, it is clear that the pattern of …
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211
M Yamaguchi, K Tobinai, M Oguchi… - Journal of clinical …, 2009 - ascopubs.org
Purpose To explore a more effective treatment for localized nasal natural killer (NK)/T-cell
lymphoma, we conducted a phase I/II study of concurrent chemoradiotherapy. Patients and …
lymphoma, we conducted a phase I/II study of concurrent chemoradiotherapy. Patients and …
Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study
Y Yang, Y Zhu, JZ Cao, YJ Zhang… - Blood, The Journal …, 2015 - ashpublications.org
The optimal combination and sequence of radiotherapy (RT) and chemotherapy (CT) for
extranodal nasal-type natural killer/T-cell lymphoma (NKTCL) are not well-defined. The aim …
extranodal nasal-type natural killer/T-cell lymphoma (NKTCL) are not well-defined. The aim …
Treatments and outcomes of patients with extranodal natural killer/T-cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan
M Yamaguchi, R Suzuki, M Oguchi, N Asano… - Journal of Clinical …, 2017 - ascopubs.org
Purpose To elucidate the management and outcomes of patients with extranodal natural
killer/T-cell lymphoma, nasal type (ENKL), who were diagnosed between 2000 and 2013 in …
killer/T-cell lymphoma, nasal type (ENKL), who were diagnosed between 2000 and 2013 in …
A critical review on properties and applications of microbial l-asparaginases
PR Krishnapura, PD Belur… - Critical reviews in …, 2016 - Taylor & Francis
Abstract l-Asparaginase is one of the main drugs used in the treatment of acute
lymphoblastic leukemia (ALL), a commonly diagnosed pediatric cancer. Although several …
lymphoblastic leukemia (ALL), a commonly diagnosed pediatric cancer. Although several …
Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma)
CE Dearden, R Johnson, R Pettengell… - British journal of …, 2011 - Wiley Online Library
The peripheral T‐cell neoplasms are a biologically and clinically heterogeneous group of
rare disorders that result from clonal proliferation of mature post‐thymic lymphocytes …
rare disorders that result from clonal proliferation of mature post‐thymic lymphocytes …
[HTML][HTML] Molecular analysis of L-asparaginases for clarification of the mechanism of action and optimization of pharmacological functions
MV Pokrovskaya, VS Pokrovsky, SS Aleksandrova… - Pharmaceutics, 2022 - mdpi.com
L-asparaginases (EC 3.5. 1.1) are a family of enzymes that catalyze the hydrolysis of L-
asparagine to L-aspartic acid and ammonia. These proteins with different biochemical …
asparagine to L-aspartic acid and ammonia. These proteins with different biochemical …